David Topper

David Topper is a Partner at Frazier Healthcare Partners, a life sciences venture capital firm and currently serves as CFO and Board Director of Frazier Lifesciences Acquisition Corporation, a SPAC sponsored by Frazier Healthcare Partners. Prior to this, David Topper was an Operating Partner of General Atlantic, a leading global growth equity firm. In his role, he managed the firm's relationships with banks, coordinated its capital markets activities, and provided strategic advice to the firms’ portfolio companies. During his tenure at General Atlantic, David served on the boards of multiple portfolio companies including Amherst Pierpont Securities, Affinion, Meteo, TASC and Engility. Prior to General Atlantic, David served as Head of Equity Capital Markets at J.P. Morgan. Before joining J.P. Morgan in 2005, he spent 22 years at Morgan Stanley where he served as Head of Equity Capital Markets, Managing Director and Chairman of the Commitments Committee. David serves on the Board of the Stanford Institute of Economic Policy Research and previously served on the board of visitors of the Duke University Trinity School of Arts and Sciences, the Board of Trustees of the Jewish Museum of New York, and The Board of Directors of the Adams Memorial Foundation. David received his B.A from Duke University and his M.B.A from Stanford University.